Kenneth R. Peak Brain & Pituitary Treatment Center

Now, 1 year and 4 months later, Stratton is a 2020 graduate from Texas A&M Galveston. 

Learn more about our gene therapy clinical trial at the Peak Center

Today, over 2 years and 3 months later, Ed is the first patient in the world to be re-treated with the experimental gene therapy and he continues to defy the odds. 

Matt Futer was given less than 3 months to live when he was initially diagnosed with glioblastoma. After successful treatment of the experimental gene therapy, Matt has been cancer free for over 7 years. 

The Peak Center has developed an experimental magnetic device in the form of an easily wearable and removable helmet. It generates concentrated, oscillating frequencies and patterns that have been shown to destroy brain cancer by targeting and disrupting dysfunctional energy production in the cancer cells.

Patients do not have to shave their heads and only 6 hours of treatment time is required per day.

Request more information on this experimental treatment here.

Not long ago, Stephany Gonzalez was diagnosed with diffuse intrinsic pontine glioma, or DIPG, which is an aggressive and malignant tumor found in the middle of the brainstem normally found in children. But this astonishing research with the oncomagentic helmet conducted by Dr. David Baskin, his team at the Peak Center, and research institute scientist Dr. Santosh Helekar is showing dramatic promise. Learn more about her first introduction to the groundbreaking research here and read about her incredible results here.

Unlike other experimental magnetic devices, the helmet works without direct contact, so there's no scalp irritation and patients don't have to shave their head. Under current Houston Methodist protocol, patients wear it for two hours at a time, twice or three times a day — a significant quality-of-life advantage over other devices intended to be worn at least 20 hours a day. Learn more.